1. Home
  2. AGIG vs SCLX Comparison

AGIG vs SCLX Comparison

Compare AGIG & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGIG

Abundia Global Impact Group Inc. Common stock

N/A

Current Price

$0.91

Market Cap

49.4M

Sector

Energy

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.86

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIG
SCLX
Founded
N/A
2011
Country
United States
United States
Employees
2
34
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.4M
52.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AGIG
SCLX
Price
$0.91
$6.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
157.7K
107.4K
Earning Date
05-19-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.97
$4.20
52 Week High
$5.31
$34.27

Technical Indicators

Market Signals
Indicator
AGIG
SCLX
Relative Strength Index (RSI) 28.73 47.46
Support Level N/A $5.72
Resistance Level $1.26 $7.77
Average True Range (ATR) 0.08 0.85
MACD -0.02 -0.08
Stochastic Oscillator 11.68 40.18

Price Performance

Historical Comparison
AGIG
SCLX

About AGIG Abundia Global Impact Group Inc. Common stock

Abundia Global Impact Group Inc. is a technology solutions company operating in recycling, renewable energy, environmental change, fuels, and chemicals sectors, mainly focused on low-carbon energy solutions. The company uses waste plastics and biomass to produce crude or drop-in alternatives to fossil-derived energy, fuels, and chemicals through proprietary, licensed, and commercialized technologies, forming a complete process. It operates through its subsidiary and integrates feedstocks, technology, and off-take partners into a complete commercial chain. Its segments include Oil and Gas (O&G), which generates maximum revenue, and Renewables, which consists of its low-carbon fuels and renewable chemicals business.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: